Articles

A group of investigators led by Dr Stuart Weinzimer of Yale University School of Medicine in New Haven, CT, USA, compared the safety and efficacy of continuous subcutaneous insulin infusion (CSII) using insulin aspart with insulin lispro in children and adolescents with type 1 diabetes.

Antianginal agent, ranolazine, reduced incidence of newly increased HbA1c in people without diabetes.

In the current issue of Diabetes Care, Davis et al. report on a small study exploring the safety of substituting exenatide for insulin therapy in an attempt to take patients off insulin.

Increasing calcium formation in the coronary arteries (CAC) is the best predictor of a coronary artery disease (CAD) event in patients with type 1 diabetes, researchers report

Too little sleep or too much may increase the risk of type 2 diabetes, according to the results of a new study.

The US FDA has granted an additional indication for rosuvastatin (Crestor, AstraZeneca), as an adjunct to diet to slow the progression of atherosclerosis in patients with elevated cholesterol.

Men who stay highly active with age may have a lower risk of developing diabetes than those who taper off their exercise levels, a study suggests.

Based on the results of the SERENADE study, showing an improvement in blood glucose control with rimonabant 20mg, the European Commission will endorse the opinion of the European Commission to include it into the label..

Screening overweight and obese adults for pre-diabetes is cost-effective, according to a study by researchers at RTI International, the Centers for Disease Control and Prevention.

Diabetes patients who used second-generation sulfonylureas had no excess one-year mortality after a myocardial infarction, researchers said….